Patents by Inventor Ikue Kudo

Ikue Kudo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating ischemic disease by intramuscular administration of Hepatocyte growth factor
    Patent number: 6887477
    Abstract: Preparations to be administered for treating or preventing ischemic diseases or arterial diseases which contain Hepatocyte growth factor (HGF) as an active ingredient. The preparations provide such effect that HGF concentration in an affected region to which HGF was administered is maintained, a half-life is longer, a dose can be reduced, and other organs except the affected region are less affected in comparison with intravenous administration.
    Type: Grant
    Filed: August 4, 1999
    Date of Patent: May 3, 2005
    Inventors: Tomokazu Nagano, Ikue Kudo, Takao Kawamura, Mutsuo Taiji, Hiroshi Noguchi, Shunsuke Tani, Hiroo Maeda
  • Method for treatment of renal failure and occlusive lesion of blood vessels by administration of hepatocyte growth factor
    Patent number: 6869609
    Abstract: The invention presents a preparation for continuous intravenous administration containing hepatocyte growth factor (HGF) as an active ingredient. The preparation for continuous administration of the invention is effective at a lower dose as compared with single or frequent bolus administration of HGF, and therefore side effects can be reduced.
    Type: Grant
    Filed: December 3, 1998
    Date of Patent: March 22, 2005
    Assignee: Sumitomo Pharmaceuticals Co., Ltd.
    Inventors: Naoki Yamazaki, Tomokazu Nagano, Ikue Kudo, Michitoshi Sekine
  • Method of treating rhabdomyolysis by administering hepatocyte growth factor
    Patent number: 6436388
    Abstract: The present invention is drawn to a method of treating acute renal failure caused by rhabdomyolysis by administering a therapeutically effective amount of hepatocyte growth factor (HGF). The present invention is further drawn to a method of treating rhabdomyolysis by administering a therapeutically effective amount of hepatocyte growth factor (HGF).
    Type: Grant
    Filed: February 24, 2000
    Date of Patent: August 20, 2002
    Inventors: Ikue Kudo, Tomokazu Nagano
  • HGF FOR TREATING ACUTE RENAL FAILURE
    Publication number: 20010047079
    Abstract: The present invention provides a pharmaceutical composition for treating acute renal failure caused by rhabdomyolysis comprising an effective amount of HGF.
    Type: Application
    Filed: February 24, 2000
    Publication date: November 29, 2001
    Inventors: IKUE KUDO, TOMOKAZU NAGANO